Dr. Hu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Saint Louis University School of MedicineClass of 2000
Clinical Trials
- Compare Pharmacokinetics, Safety, and Immunogenicity of HLX11 vs. Perjeta in Healthy Chinese Male Subjects Start of enrollment: 2020 Jul 01
Publications & Presentations
PubMed
- 64 citationsAdrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian CancerYu Kang, Archana S. Nagaraja, Guillermo N. Armaiz-Pena, Piotr L. Dorniak, Wei Hu
Clinical Cancer Research. 2016-04-01 - 149 citationsFABP4 as a key determinant of metastatic potential of ovarian cancerKshipra M. Gharpure, Sunila Pradeep, Marta Sans, Rajesha Rupaimoole, Cristina Ivan
Nature Communications. 2018-07-26 - 44 citationsMethylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies.Gerald S. Falchook, Siqing Fu, Aung Naing, David S. Hong, Wei Hu
Investigational New Drugs. 2013-08-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
